Trial intelligence / Profile preview

Botulax vs Botox in Post Stroke Upper Limb Spasticity

NCT01915459Phase 3Completed

Sponsor
Hugel
Start
Jun 2013
Primary completion
May 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by Hugel. Started Jun 2013; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

spasticity

Beyond the preview

Go deeper on NCT01915459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01915459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call